Skip to main content
Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales?
Nanoparticle Delivery of Angiogenic Gene Therapy. Save the Vessels, Save the Lung!
Equipoise and Acumen in Pediatric Acute Respiratory Distress Syndrome Research.
Pulmonary Vascular Disease in Premature Infants. Early Predictive Models of Late Respiratory Morbidity.
Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome.
Metagenomic Sequencing Detects Respiratory Pathogens in Hematopoietic Cellular Transplant Patients.
The Prescient Prognosticator? Hepatoma-derived Growth Factor in Pulmonary Hypertension.
Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.
Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.
Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.